GET THE APP

Simultaneous spectrophotometric estimation of gemifloxacin and ambroxol from tablet formulation
..

Pharmaceutical Regulatory Affairs: Open Access

ISSN: 2167-7689

Open Access

Simultaneous spectrophotometric estimation of gemifloxacin and ambroxol from tablet formulation


2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

November 23-24, 2012 Hyderabad International Convention Centre, India

Khan Hajera

Accepted Abstracts: Pharmaceut Reg Affairs

Abstract :

Two simple, accurate and precise UV methods were developed for the estimation of Gemifloxacin (GEM) and Ambroxol hydrochloride (AMB). from its tablet dosage form. Both the drugs are used in treatment of chronic bronchitis and mild to moderate pneumonia. The muscle spasm. Method I is Simultaneous equation method, wavelengths selected for Quantitation are 271.0 nm and 245.5 nm for c respectively which are the λmax of both the drugs. Method II is Q ?Analysis method, wavelengths selected were 271nm (λmax of GEM) and 244.0 nm (Isobestic point) for the analysis. In both the methods linearity for detector response was observed in the concentration range of 10-60 μg/ml for GEM and2-12 μg/ml for AMB respectively. The results of tablet analysis for method I is found to be 99.97% + 0.041 S.D for GEM and 99.93% + 0.21 S.D for AMB and results obtained for Method II is 99.94% + 0.080 S.D for GEM and 99.90% + 0.15 S.D for AMB. The proposed methods were successfully applied for the simultaneous determination of both the drugs in commercial tablet preparation. The results of the analysis have been validated statistically.

Biography :

Khan Hajera has completed her M.Pharmacy in Quality Assurance from BAMU University in 2011 .She has published 8 research papers in reputed National and international journals and presently working as assistant professor in pharmacy college.

Google Scholar citation report
Citations: 533

Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report

Pharmaceutical Regulatory Affairs: Open Access peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward